Atossa Genetics (ATOS) Launches COVID-19 HOPE Drug Development Program
Go back to Atossa Genetics (ATOS) Launches COVID-19 HOPE Drug Development Program| ATOSSA GNTCS (NASDAQ: ATOS) | Delayed: 1.90 +0.07 (3.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.83 | 52 Week High | $3.64 | |||
| Open | $1.82 | 52 Week Low | $0.14 | |||
| Day High | $1.96 | P/E | N/A | |||
| Day Low | $1.78 | EPS | $0.00 | |||
| Volume | 534,936 | |||||

